SCHEMBL9293338

SCHEMBL9293338

CN(C)CCOc1ccc(O)c(C=NCCN=Cc2cc(OCCN(C)C)ccc2O)c1.O=[V]

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 5/20 0.49
▸ CHRNB2 P17787 2/20 0.46
▸ CHRNA4 P43681 2/20 0.46
▸ KDM4E B2RXH2 6/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ CA1 P00915 2/20 0.44
▸ KMT2A Q03164 1/20 0.41
▸ LMNA P02545 1/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.39
▸ HSP90B1 P14625 1/20 0.39
▸ TRAP1 Q12931 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ KEAP1 Q14145 1/20 0.38
▸ NFE2L2 Q16236 1/20 0.38
▸ LTA4H P09960 1/20 0.38
▸ APP P05067 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8761203 0.96 CA2 (0.49) CA2CHRNB2CHRNA4KDM4EALDH1A1
SCHEMBL8761193 0.90 CHRNB2 (0.49) CA2CHRNB2CHRNA4KDM4EALDH1A1
SCHEMBL8761388 0.85 CHRNB2 (0.52) CA2CHRNB2CHRNA4KDM4EALDH1A1
SCHEMBL8761047 0.81 ERN1 (0.57) CHRNB2CHRNA4KDM4EALDH1A1LMNA
SCHEMBL9293024 0.76 KDM4E (0.52) CHRNB2CHRNA4KDM4EALDH1A1KMT2A
SCHEMBL4345964 0.74 CA2 (0.74) CA2KDM4EALDH1A1CA1KMT2A
SCHEMBL4345961 0.74 CA2 (0.74) CA2KDM4EALDH1A1CA1KMT2A
SCHEMBL7600443 0.73 CA2 (0.44) CA2KDM4EALDH1A1CA1KMT2A
SCHEMBL7599962 0.73 CA2 (0.44) CA2KDM4EALDH1A1CA1KMT2A
SCHEMBL7599960 0.73 CA2 (0.44) CA2KDM4EALDH1A1CA1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278154-A New vanadium complexes ADIR ET COMPAGNIE (FR) 1994-01-11 — — US disclosed
US-5266565-A Antidiabetic ADIR ET COMPAGNIE (FR) 1993-11-30 — — US disclosed
Send feedback